Endothelial cell clonal expansion in the development of cerebral cavernous malformations.
Matteo MalinvernoClaudio MadernaAbdallah Abu TahaMonica CoradaFabrizio OrsenigoMariaelena ValentinoFederica PisatiCarmela FuscoPaolo GrazianoMonica GiannottaQing Cissy YuYi Arial ZengMaria Grazia LampugnaniPeetra Ulrica MagnussonElisabetta DejanaPublished in: Nature communications (2019)
Cerebral cavernous malformation (CCM) is a neurovascular familial or sporadic disease that is characterised by capillary-venous cavernomas, and is due to loss-of-function mutations to any one of three CCM genes. Familial CCM follows a two-hit mechanism similar to that of tumour suppressor genes, while in sporadic cavernomas only a small fraction of endothelial cells shows mutated CCM genes. We reported that in mouse models and in human patients, endothelial cells lining the lesions have different features from the surrounding endothelium, as they express mesenchymal/stem-cell markers. Here we show that cavernomas originate from clonal expansion of few Ccm3-null endothelial cells that express mesenchymal/stem-cell markers. These cells then attract surrounding wild-type endothelial cells, inducing them to express mesenchymal/stem-cell markers and to contribute to cavernoma growth. These characteristics of Ccm3-null cells are reminiscent of the tumour-initiating cells that are responsible for tumour growth. Our data support the concept that CCM has benign tumour characteristics.
Keyphrases
- endothelial cells
- induced apoptosis
- mesenchymal stem cells
- high glucose
- cell cycle arrest
- vascular endothelial growth factor
- genome wide
- bone marrow
- late onset
- endoplasmic reticulum stress
- oxidative stress
- nitric oxide
- early onset
- cell death
- subarachnoid hemorrhage
- gene expression
- machine learning
- ejection fraction
- dna methylation
- electronic health record
- transcription factor
- patient reported outcomes
- peritoneal dialysis
- data analysis